We hypothesize that inhibiting TNF-α, IL-1β, and ΙL-6 and increasing IL-10 along with activation of leucocyte and macrophage PPAR-γ, thereby normalizing MAP in SIR-mediated AKI and hypotension. This evidence concerns the gene IL10 and acute kidney injury.